SMO ClinPlus CO.,LTD. (SHE:301257)

China flag China · Delayed Price · Currency is CNY
30.12
+0.36 (1.21%)
At close: Jun 27, 2025, 2:57 PM CST
10.33%
Market Cap 2.49B
Revenue (ttm) 803.73M
Net Income (ttm) 106.43M
Shares Out 79.50M
EPS (ttm) 1.35
PE Ratio 19.27
Forward PE 22.67
Dividend 0.18 (0.57%)
Ex-Dividend Date Jun 20, 2025
Volume 1,482,500
Average Volume 2,514,582
Open 29.75
Previous Close 29.76
Day's Range 29.67 - 30.15
52-Week Range 23.07 - 39.45
Beta 0.91
RSI 55.40
Earnings Date Aug 29, 2025

About SMO ClinPlus CO.,LTD.

SMO ClinPlus CO.,LTD. provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China. The company’s SMO services include preliminary model establishment, preliminary plan preparation, initiation of clinical trial sites, on-site implementation, and project management services. SMO ClinPlus CO.,LTD. was founded in 2009 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 2009
Employees 4,186
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301257
Full Company Profile

Financial Performance

In 2024, SMO ClinPlus CO.,LTD.'s revenue was 803.73 million, an increase of 5.75% compared to the previous year's 760.04 million. Earnings were 106.43 million, a decrease of -21.01%.

Financial Statements

News

There is no news available yet.